XTX Topco’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $277K | Buy |
+121,899
| New | +$277K | 0.01% | 1492 |
|
2025
Q1 | – | Sell |
-32,922
| Closed | -$33.9K | – | 2526 |
|
2024
Q4 | $33.9K | Sell |
32,922
-10,742
| -25% | -$11.1K | ﹤0.01% | 1953 |
|
2024
Q3 | $51.5K | Sell |
43,664
-16,922
| -28% | -$20K | ﹤0.01% | 1685 |
|
2024
Q2 | $73.9K | Buy |
60,586
+48,033
| +383% | +$58.6K | 0.01% | 1458 |
|
2024
Q1 | $27.4K | Sell |
12,553
-7,720
| -38% | -$16.8K | ﹤0.01% | 1571 |
|
2023
Q4 | $31.4K | Buy |
+20,273
| New | +$31.4K | 0.01% | 1300 |
|
2023
Q2 | – | Sell |
-17,815
| Closed | -$26.9K | – | 1482 |
|
2023
Q1 | $26.9K | Sell |
17,815
-11,762
| -40% | -$17.8K | 0.01% | 1201 |
|
2022
Q4 | $47.3K | Sell |
29,577
-15,271
| -34% | -$24.4K | 0.01% | 1046 |
|
2022
Q3 | $65K | Sell |
44,848
-55,756
| -55% | -$80.8K | 0.02% | 1002 |
|
2022
Q2 | $184K | Sell |
100,604
-17,735
| -15% | -$32.4K | 0.08% | 486 |
|
2022
Q1 | $316K | Buy |
118,339
+108,174
| +1,064% | +$289K | 0.14% | 250 |
|
2021
Q4 | $44K | Buy |
+10,165
| New | +$44K | 0.02% | 578 |
|
2021
Q3 | – | Sell |
-21,422
| Closed | -$136K | – | 748 |
|
2021
Q2 | $136K | Buy |
+21,422
| New | +$136K | 0.05% | 623 |
|